Quality matters: International standards for biobanking
- PMID: 35709534
- PMCID: PMC9357355
- DOI: 10.1111/cpr.13282
Quality matters: International standards for biobanking
Abstract
Human biospecimens provide the basis for research, leading to a better understanding of human disease biology and discovery of new treatments that are tailored to individual patients with cancer or other common complex diseases. The collection, processing, preservation, storage and providing access to these resources are key activities of biobanks. Biobanks must ensure proper quality of samples and data, ethical and legal compliance as well as transparent and efficient access procedures. The standards for biobanking outlined herein are intended to be implemented in biobanks and to supply researchers with high-quality samples fitted for an intended use.
© 2022 The Author. Cell Proliferation published by European Cell Proliferation Society and John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare that there are no conflicts of interest.
References
-
- Simeon‐Dubach D, Kozlakidis Z. New standards and updated best practices will give modern biobanking a boost in professionalism. Biopreserv Biobank. 2018;16(1):1‐2. - PubMed
-
- Aspinall MG, Hamermesh RG. Realizing the promise of personalized medicine. Harv Bus Rev. 2007;85(10):108‐117. - PubMed
-
- Compton C. Getting to personalized cancer medicine: taking out the garbage. Cancer. 2007;110(8):1641‐1643. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources